Apollomics (APLM) Total Current Liabilities (2021 - 2025)
Apollomics' (APLM) quarterly Total Current Liabilities came in at $388000.0 in Q4 2025, down 93.19% year-over-year from $5.7 million in Q4 2024, and down 40.03% quarter-over-quarter from $647000.0 in Q2 2025.
Analysis
Apollomics (APLM) Total Current Liabilities (2021 - 2025) Analysis & Trends
Apollomics (APLM) has reported Total Current Liabilities for 5 consecutive years, with $388000.0 the latest figure, recorded in Q4 2025.
- On a quarterly basis, Total Current Liabilities fell 93.19% year-over-year to $388000.0 in Q4 2025; TTM through Dec 2025 was $388000.0, a 93.19% decrease from a year earlier, with the FY2025 full-year figure at $388000.0, down 93.19% from the prior year.
- Total Current Liabilities was $388000.0 for Q4 2025 at Apollomics, down from $647000.0 in the prior quarter.
- Over five years, Total Current Liabilities peaked at $109.9 million in Q4 2021 and troughed at $388000.0 in Q4 2025.
- A 5-year average of $37.7 million and a median of $31.9 million in 2023 frame the typical range for Total Current Liabilities.
- Across the five-year window, Total Current Liabilities plunged 34.76% in 2023 and slumped 97.05% in 2025, its largest moves.
- Over 5 years, Total Current Liabilities stood at $109.9 million in 2021, then slumped by 41.65% to $64.1 million in 2022, then sank by 34.76% to $41.8 million in 2023, then plunged by 86.38% to $5.7 million in 2024, then plunged by 93.19% to $388000.0 in 2025.
- The last three Total Current Liabilities figures came in at $388000.0 (Q4 2025), $647000.0 (Q2 2025), and $5.7 million (Q4 2024), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 25.50 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | 11.02 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | 3.94 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 5.53 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | 1.58 Bn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | 2.53 Bn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | 1.51 Bn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | 3.92 Bn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | 283.60 Mn |
| 10 | Apollomics | 34.50 Mn | 31.23 Mn | - | 388,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 388,000.00 |
| Jun 30, 2025 | 647,000.00 |
| Dec 31, 2024 | 5.70 Mn |
| Jun 30, 2024 | 21.92 Mn |
| Dec 31, 2023 | 41.83 Mn |
| Jun 30, 2023 | 57.24 Mn |
| Dec 31, 2022 | 64.12 Mn |
| Dec 31, 2021 | 109.88 Mn |